Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis

Tumor Biology

Volumn 36, Issue 1, 2015, Pages 121-127

  Chen, Peiqin ^a   Chen, Chao ^b   Chen, Kun ^a   Xu, Tao ^a   Luo, Chun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Interleukin 13; Interleukin 4; Interleukin 4R; Meta analysis; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; IL4 PROTEIN, HUMAN; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN-13, HUMAN;

CANCER RISK; CLINICAL ASSESSMENT; COCHRANE LIBRARY; EMBASE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GLIOMA; HIGH RISK PATIENT; HUMAN; INFORMATION; MEDLINE; META ANALYSIS; POPULATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; WEB OF SCIENCE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-4; RISK; SIGNAL TRANSDUCTION;

EID: 84925465320     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2895-8     Document Type: Review

References (38)

1. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93–108. doi:10.1007/s00401-005-0991-y.
2. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2(9):494–503. doi:10.1038/ncpneuro0289. quiz 1 p following 16.
3. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, van Tongeren M, Muir KR. History of allergies and risk of glioma in adults. Int J Cancer. 2006;119(9):2165–72. doi:10.1002/ijc.22091.
4. Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, et al. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166(8):941–50. doi:10.1093/aje/kwm203.
5. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst. 2007;99(20):1544–50. doi:10.1093/jnci/djm170.
6. Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, et al. Allergy and risk of glioma: a meta-analysis. Eur J Neurol. 2011;18(3):387–95. doi:10.1111/j.1468-1331.2010.03187.x.
7. Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011;103(21):1588–95. doi:10.1093/jnci/djr361.
8. Schlehofer B, Siegmund B, Linseisen J, Schuz J, Rohrmann S, Becker S, et al. Primary brain tumours and specific serum immunoglobulin E: a case–control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011;66(11):1434–41. doi:10.1111/j.1398-9995.2011.02670.x.
9. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006;18(6):738–44. doi:10.1016/j.coi.2006.06.003.
10. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol. 1998;102(2):165–9. doi:10.1016/S0091-6749(98)70080-6.
11. Barna BP, Estes ML, Pettay J, Iwasaki K, Zhou P, Barnett GH. Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression. J Neuroimmunol. 1995;60(1–2):75–81. doi:10.1016/0165-5728(95)00055-7.
12. Liu H, Jacobs BS, Liu J, Prayson RA, Estes ML, Barnett GH, et al. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother. 2000;49(6):319–24. doi:10.1007/s002620000110.
13. Loza MJ, Chang BL. Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. J Allergy Clin Immunol. 2007;120(3):578–85. doi:10.1016/j.jaci.2007.05.019.
14. Cui L, Jia J, Ma CF, Li SY, Wang YP, Guo XM, et al. IL-13 polymorphisms contribute to the risk of asthma: a meta-analysis. Clin Biochem. 2012;45(4–5):285–8. doi:10.1016/j.clinbiochem.2011.12.012.
15. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H, et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 2005;65(14):6459–65. doi:10.1158/0008-5472.CAN-04-3728.
16. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1229–35. doi:10.1158/1055-9965.EPI-07-0041.
17. Schwartzbaum JA, Ahlbom A, Lonn S, Malmer B, Wigertz A, Auvinen A, et al. An international case–control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2448–54. doi:10.1158/1055-9965.EPI-07-0480.
18. Guo J, Shi L, Li M, Xu J, Yan S, Zhang C, et al. Association of the interleukin-4Ralpha rs1801275 and rs1805015 polymorphisms with glioma risk. Tumour Biol. 2013. doi:10.1007/s13277-013-1080-9.
19. Sun G, Wang X, Shi L, Yue X, Fu L, Chen C, et al. Association between polymorphisms in interleukin-4Ralpha and interleukin-13 and glioma risk: a meta-analysis. Cancer Epidemiol. 2013;37(3):306–10. doi:10.1016/j.canep.2013.01.003.
20. Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis. 2007;28(12):2543–7. doi:10.1093/carcin/bgm210.
21. Amirian E, Liu Y, Scheurer ME, El-Zein R, Gilbert MR, Bondy ML. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010;12(5):444–52. doi:10.1093/neuonc/nop057.
22. Walsh KM, Anderson E, Hansen HM, Decker PA, Kosel ML, Kollmeyer T, et al. Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies. Genet Epidemiol. 2013;37(2):222–8. doi:10.1002/gepi.21707.
23. Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM, Ma J, et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013;113(2):229–38. doi:10.1007/s11060-013-1122-6.
24. Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, et al. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer. 2006;9(4):284–90. doi:10.1007/s10120-006-0392-5.
25. Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS, et al. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2011;125(3):827–35. doi:10.1007/s10549-010-0995-8.
26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi:10.1002/sim.1186.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. doi:10.1016/0197-2456(86)90046-2.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48. doi:10.1093/jnci/22.4.719.
29. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80. doi:10.1001/jama.295.6.676.
30. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905–8. doi:10.1038/ng.408.
31. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011;20(14):2897–904. doi:10.1093/hmg/ddr192.
32. Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, et al. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014;46(7):731–5. doi:10.1038/ng.3004.
33. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899–904. doi:10.1038/ng.407.
34. Li W, Qian X, Teng H, Ding Y, Zhang L. Association of interleukin-4 genetic polymorphisms with sporadic Alzheimer’s disease in Chinese Han population. Neurosci Lett. 2014;563:17–21. doi:10.1016/j.neulet.2014.01.019.
35. Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol. 2004;31(6):1206–10.
36. Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg KC, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer. 2003;106(3):423–8. doi:10.1002/ijc.11230.
37. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999;82(2):155–60. doi:10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P.
38. Maier LM, Howson JM, Walker N, Spickett GP, Jones RW, Ring SM, et al. Association of IL13 with total IgE: evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol. 2006;117(6):1306–13. doi:10.1016/j.jaci.2005.12.1354.